Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

December 25, 2017
Otsuka Pharmaceutical Factory

Otsuka to Invest in Megakaryon Corporation, with the Aim to Advance Commercialization of iPS-cell-derived Platelet Preparations
December 25, 2017
Otsuka Pharmaceutical

Otsuka and DKSH to commence sales of Otsuka prescription drugs in Myanmar
December 25, 2017
Otsuka Pharmaceutical

Otsuka to Invest in Megakaryon Corporation, with the Aim to Advance Commercialization of iPS-cell-derived Platelet Preparations
December 20, 2017
Otsuka Pharmaceutical

Otsuka and X-Chem Enter into a Drug Discovery Research and License Collaboration
December 19, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Establishes Joint Research Chair for Women's Health Promotion with Hirosaki University Graduate School of Medicine
December 18, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Signs a Co-promotion Agreement with Janssen Pharmaceutical K.K. for Guselkumab, a Human Anti-interleukin (IL)-23 Monoclonal Antibody, in Japan
December 14, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Co., Ltd. Receives the Japan Medical R&D Grand Prize for Development of Delamanid, a Drug for Multidrug-resistant Tuberculosis Japanese Government Grants Award for the First Time
December 13, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Unveils It's Completely New Website
December 12, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Receives Newly Established "Sports Yell Company" Certification from Japan Sports Agency
December 8, 2017
Otsuka Pharmaceutical

Observational study of 88 female Kindai University athletes Relationship between premenstrual syndrome-induced interference in athletic performance and equol production status
November 29, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Launch New, Pre-mixed Flavor Formulations (Fruit and Coffee) for Aminoleban EN, an Oral Nutritional Supplement for Patients with Liver Failure
November 29, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches New Formulations in Japan of L-Cartin® for Carnitine Deficiencies
November 21, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters Into Comprehensive Regional Revitalization Partnership Agreement with Yamaguchi Prefecture
November 20, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Cooperates with Community Health Promotion Efforts Tokushima Itano Factory Sponsors "Asan Walking Festa in Itano"
November 17, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Head Office to Temporarily Relocate
November 15, 2017
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory announces REHADAYS to help make body strong launched on November 15, 2017
November 15, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Become a Sponsor of the 18th Asian Games
November 14, 2017
Otsuka Pharmaceutical

Otsuka and Proteus Announce the First U.S. FDA Approval of a Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)
November 14, 2017
Otsuka Holdings Otsuka Medical Devices

Notice Regarding Company Split (Simplified Absorption–type Company Split)
November 10, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Constructs Otsuka Group's Kitajima Plant Welfare and Office Building
November 9, 2017
Otsuka Pharmaceutical

U.S. FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of ADPKD
November 9, 2017
Otsuka Holdings Otsuka Pharmaceutical

FDA ACCEPTS OTSUKA’S RESUBMISSION TO SUPPORT A REGULATORY REVIEW OF TOLVAPTAN IN THE TREATMENT OF ADPKD
November 8, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Comprehensive Cooperative Partnership with Oita Prefecture
November 6, 2017
Otsuka Pharmaceutical

Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
November 6, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
November 2, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Tokushima Wajiki Factory Receives 2017 Minister of Economy, Trade and Industry Award for Excellent Greening, a First for the Shikoku Region
November 1, 2017
Otsuka Pharmaceutical

Otsuka and Lundbeck will Initiate a Third Phase 3 Trial to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Dementia of the Alzheimer's Type
November 1, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka and Lundbeck will initiate a third Phase 3 trial to evaluate brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer's type
October 31, 2017
Otsuka Pharmaceutical

US Launch of EQUELLE, a Dietary Supplement to Support Women's Health
October 30, 2017
Taiho Pharmaceutical

Taiho to Donate a Total of JPY 55 Million to 15 Organizations Related to Cancer and Health, to Mark its 55th Anniversary